Trial intelligence / Profile preview

Sonothrombolysis in STEMI

NCT03092089Phase 2Completed

Start
Aug 2017
Primary completion
Oct 2019
Modality
Drug Delivery Systems
Countries
1
01

Overview

A Phase 2 trial of perflutren lipid microspheres in ST-segment elevation myocardial infarction (STEMI). Started Aug 2017; status: completed.

02

Drugs

perflutren lipid microspheres
03

Conditions

ST-segment elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT03092089.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03092089.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call